The two types of auto-immune pancreatitis;Les deux formes de la pancréatite auto-immune

Presse Medicale

Volumn 41, Issue 6 PART 1, 2012, Pages 580-592

  Rebours, Vinciane ^a   Lévy, Philippe ^a  

^a CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G4; STEROID;

AUTOIMMUNE PANCREATITIS; AUTOIMMUNE PANCREATITIS TYPE 1; AUTOIMMUNE PANCREATITIS TYPE 2; DISEASE CLASSIFICATION; ENTERITIS; GRANULOCYTE; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; SHORT SURVEY;

EID: 84861981774     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.09.020     Document Type: Short Survey

References (54)

1. Sarles H., Sarles J.C., Muratore R., Guien C. Chronic inflammatory sclerosis of the pancreas: an autonomous pancreatic disease?. Am J Dig Dis 1961, 6:688-698.
2. Kawaguchi K., Koike M., Tsuruta K., Okamoto A., Tabata I., Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991, 22(4):387-395.
3. Yoshida K., Toki F., Takeuchi T., Watanabe S., Shiratori K., Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995, 40(7):1561-1568.
4. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344(10):732-738.
5. Kamisawa T., Egawa N., Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003, 98(12):2811-2812.
6. Kwon S., Kim M.H., Choi E.K. The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas 2007, 34(3):279-286.
7. Otsuki M., Chung J.B., Okazaki K., Kim M.H., Kamisawa T., Kawa S., et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008, 43(6):403-408.
8. Notohara K., Burgart L.J., Yadav D., Chari S., Smyrk T.C. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003, 27(8):1119-1127.
9. Chari S.T., Smyrk T.C., Levy M.J., Topazian M.D., Takahashi N., Zhang L., et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006, 4(8):1010-1016. [quiz 934].
10. Zamboni G., Luttges J., Capelli P., Frulloni L., Cavallini G., Pederzoli P., et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004, 445(6):552-563.
11. Sah R.P., Chari S.T., Pannala R., Sugumar A., Clain J.E., Levy M.J., et al. Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology 2010, 139(1):140-148. [quiz e12-e13].
12. Kamisawa T., Notohara K., Shimosegawa T. Two clinicopathologic subtypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology 2010, 139(1):22-25.
13. Zen Y., Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol 2011, 23(1):114-118.
14. Ravi K., Chari S.T., Vege S.S., Sandborn W.J., Smyrk T.C., Loftus E.V. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm Bowel Dis 2009, 15(9):1326-1330.
15. Maire F., Le Baleur Y., Rebours V., Vullierme M.P., Couvelard A., Voitot H., et al. Outcome of patients with type 1 or 2 autoimmune pancreatitis. Am J Gastroenterol 2011, 106(1):151-156.
16. Kawa S., Ota M., Yoshizawa K., Horiuchi A., Hamano H., Ochi Y., et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 2002, 122(5):1264-1269.
17. Kountouras J., Zavos C., Gavalas E., Tzilves D. Challenge in the pathogenesis of autoimmune pancreatitis: potential role of Helicobacter pylori infection via molecular mimicry. Gastroenterology 2007, 133(1):368-369.
18. Chari S.T., Kloeppel G., Zhang L., Notohara K., Lerch M.M., Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document. Pancreatology 2010, 10(6):664-672.
19. Deshpande V., Gupta R., Sainani N., Sahani D.V., Virk R., Ferrone C., et al. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol 2011, 35(1):26-35.
20. Kloppel G., Luttges J., Lohr M., Zamboni G., Longnecker D. Autoimmune pancreatitis: pathological, clinical and immunological features. Pancreas 2003, 27(1):14-19.
21. Kloppel G., Sipos B., Zamboni G., Kojima M., Morohoshi T. Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol 2007, 42(Suppl. 18):28-31.
22. Levy M.J., Smyrk T.C., Takahashi N., Zhang L., Chari S.T. Idiopathic duct-centric pancreatitis: disease description and endoscopic ultrasonography-guided trucut biopsy diagnosis. Pancreatology 2011, 11(1):76-80.
23. Mizuno N., Bhatia V., Hosoda W., Sawaki A., Hoki N., Hara K., et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 2009, 44(7):742-750.
24. Moon S.H., Kim M.H., Park do H., Song T.J., Eum J., Lee S.S., et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest Endosc 2010, 71(6):960-966.
25. Kamisawa T., Tu Y., Egawa N., Nakajima H., Tsuruta K., Okamoto A. Involvement of pancreatic and bile ducts in autoimmune pancreatitis. World J Gastroenterol 2006, 12(4):612-614.
26. Nishimori I., Tamakoshi A., Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007, 42(Suppl. 18):6-8.
27. Yadav D., Notahara K., Smyrk T.C., Clain J.E., Pearson R.K., Farnell M.B., et al. Idiopathic tumefactive chronic pancreatitis: clinical profile, histology and natural history after resection. Clin Gastroenterol Hepatol 2003, 1(2):129-135.
28. Okazaki K. Autoimmune pancreatitis is increasing in Japan. Gastroenterology 2003, 125(5):1557-1558.
29. Frulloni L., Scattolini C., Falconi M., Zamboni G., Capelli P., Manfredi R., et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009, 104(9):2288-2294.
30. Raina A., Yadav D., Krasinskas A.M., McGrath K.M., Khalid A., Sanders M., et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009, 104(9):2295-2306.
31. Ghazale A., Chari S.T., Zhang L., Smyrk T.C., Takahashi N., Levy M.J., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134(3):706-715.
32. Kamisawa T., Yoshiike M., Egawa N., Nakajima H., Tsuruta K., Okamoto A. Treating patients with autoimmune pancreatitis: results from a long-term follow-up study. Pancreatology 2005, 5(2-3):234-238. [discussion 8-40].
33. Hamano H., Arakura N., Muraki T., Ozaki Y., Kiyosawa K., Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006, 41(12):1197-1205.
34. Takahashi N., Kawashima A., Fletcher J.G., Chari S.T. Renal involvement in patients with autoimmune pancreatitis: CT and MR imaging findings. Radiology 2007, 242(3):791-801.
35. Takuma K., Kamisawa T., Anjiki H., Egawa N., Igarashi Y. Metachronous extrapancreatic lesions in autoimmune pancreatitis. Intern Med 2010, 49(6):529-533.
36. Ghazale A., Chari S.T., Smyrk T.C., Levy M.J., Topazian M.D., Takahashi N., et al. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol 2007, 102(8):1646-1653.
37. Frulloni L., Lunardi C., Simone R., Dolcino M., Scattolini C., Falconi M., et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009, 361(22):2135-2142.
38. Parkkila S., Parkkila A.K., Juvonen T., Rajaniemi H. Distribution of the carbonic anhydrase isoenzymes I, II and VI in the human alimentary tract. Gut 1994, 35(5):646-650.
39. Sahani D.V., Kalva S.P., Farrell J., Maher M.M., Saini S., Mueller P.R., et al. Autoimmune pancreatitis: imaging features. Radiology 2004, 233(2):345-352.
40. Sahani D.V., Sainani N.I., Deshpande V., Shaikh M.S., Frinkelberg D.L., Fernandez-del Castillo C. Autoimmune pancreatitis: disease evolution, staging, response assessment and CT features that predict response to corticosteroid therapy. Radiology 2009, 250(1):118-129.
41. Bodily K.D., Takahashi N., Fletcher J.G., Fidler J.L., Hough D.M., Kawashima A., et al. Autoimmune pancreatitis: pancreatic and extrapancreatic imaging findings. AJR Am J Roentgenol 2009, 192(2):431-437.
42. Carbognin G., Girardi V., Biasiutti C., Camera L., Manfredi R., Frulloni L., et al. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP. Radiol Med 2009, 114(8):1214-1231.
43. Matsubayashi H., Furukawa H., Maeda A., Matsunaga K., Kanemoto H., Uesaka K., et al. Usefulness of positron emission tomography in the evaluation of distribution and activity of systemic lesions associated with autoimmune pancreatitis. Pancreatology 2009, 9(5):694-699.
44. Shigekawa M., Yamao K., Sawaki A., Hara K., Takagi T., Bhatia V., et al. Is (18)F-fluorodeoxyglucose positron emission tomography meaningful for estimating the efficacy of corticosteroid therapy in patients with autoimmune pancreatitis?. J Hepatobiliary Pancreat Sci 2010, 17(3):269-274.
45. Lee T.Y., Kim M.H., Park do H., Seo D.W., Lee S.K., Kim J.S., et al. Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 2009, 193(2):343-348.
46. Moon S.H., Kim M.H., Park D.H., Hwang C.Y., Park S.J., Lee S.S., et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 2008, 57(12):1704-1712.
47. Fattahi R., Balci N.C., Perman W.H., Hsueh E.C., Alkaade S., Havlioglu N., et al. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC) and normal pancreas. J Magn Reson Imaging 2009, 29(2):350-356.
48. Kartalis N., Lindholm T.L., Aspelin P., Permert J., Albiin N. Diffusion-weighted magnetic resonance imaging of pancreas tumours. Eur Radiol 2009, 19(8):1981-1990.
49. Kamisawa T., Shimosegawa T., Okazaki K., Nishino T., Watanabe H., Kanno A., et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009, 58(11):1504-1507.
50. Ito T., Nakamura T., Fujimori N., Niina Y., Igarashi H., Oono T., et al. Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis. J Dig Dis 2011, 12(3):210-216.
51. Ito T., Nishimori I., Inoue N., Kawabe K., Gibo J., Arita Y., et al. Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan. J Gastroenterol 2007, 42(Suppl. 18):50-58.
52. Hirano K., Tada M., Isayama H., Yagioka H., Sasaki T., Kogure H., et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007, 56(12):1719-1724.
53. Pannala R., Chari S.T. Corticosteroid treatment for autoimmune pancreatitis. Gut 2009, 58(11):1438-1439.
54. Okazaki K., Kawa S., Kamisawa T., Ito T., Inui K., Irie H., et al. Japanese clinical guidelines for autoimmune pancreatitis. Pancreas 2009, 38(8):849-866.